Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05501379

Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker

Comparison of the Physical Activity Assessed by an Accelerometer and the International Physical Activity Questionnaire in Oncologic Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University Medicine Greifswald · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Physical activity is an important aspect of cancer therapy but correct measurement of physical activity is difficult. In this study, the physical activity of patients undergoing cancer therapy is assessed by questionnaire and by motion tracker. The results are then compared to answer whether there are differences between the two measurements. Findings of this study will help to improve the assessment of physical activity in cancer patients.

Detailed description

Although physical activity has been identified as a relevant determinant of cancer therapy outcome, its valid assessment remains challenging. In principle, direct and indirect assessment instruments can be employed for assessment of physical activity. While direct instruments, e.g. accelerometers, are considered to provide a more objective measurement, indirect tools such as questionnaires are less expensive and more applicable for use in larger study populations. The validity of both forms of measurements in cancer patients is however not well studied. Therefore, this study aims to elucidate the relative validity of an accelerometer in comparison to a standardized physical questionnaire at different time points of cancer therapy. Findings of this study will allow conclusions regarding the ideal modalities for assessment of physical activity in cancer patients.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention - observational study onlyNo intervention - observational study only

Timeline

Start date
2022-09-21
Primary completion
2024-12-31
Completion
2025-03-31
First posted
2022-08-15
Last updated
2024-12-27

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05501379. Inclusion in this directory is not an endorsement.